Trademark Overview
On Thursday, May 15, 2025, a trademark application was filed for BIOCOG with the United States Patent and Trademark Office. The USPTO has given the BIOCOG trademark a serial number of 79426611. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 26, 2025. This trademark is owned by Sebastian Palmquist. The BIOCOG trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Computer programs, software or apps for mobile phones or tablet computers for medical diagnosis; computer programs, software or apps for mobile phones or tablet computers for the diagnosis of forms of dementia; computer programs, software or apps for mobile phones or tablet computers for cognitive testing; tablets or mobile phones with pre-installed computer programs, software or apps for cognitive testing.
Performing diagnosis of diseases; medical diagnostic services; medical analysis services for diagnostics and treatment purposes; medical analysis services for the diagnosis and treatment of degenerative diseases; medical care and analysis services relating to patient treatment; advisory services relating to the treatment of degenerative diseases; medical services; medical services relating to alzheimer's disease, parkinson's disease and other neurological diseases; diagnosis of alzheimer's disease, parkinson's disease and other neurological diseases.
Cognitive testing provided via software as a service [SaaS]; electronic storage of medical records; electronic storage of biodatabases; biomedical research services; clinical studies and research and development related thereto in the fields of alzheimer's disease, parkinson's disease and other neurological diseases; development of new methods and products for the detection, diagnosis and cure of alzheimer's disease, parkinson's disease and other neurological diseases; research services relating to the identification of causes of alzheimer's disease, parkinson's disease and other neurological diseases; development of new pharmaceuticals and rehabilitation methods against alzheimer's disease, parkinson's disease and other neurological diseases.
